title: New NCCN program recognizes organizations supporting coverage for clinical trials and appropriate off-label drug usage.
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009784:Occupational Diseases; D056687:Off-Label Use
chemical_list: D000970:Antineoplastic Agents